🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/03/2024 | 126,87 | 127,85 | 126,42 | 126,96 | -0,15% | 1,13% | 6.023.400 |
| 29/02/2024 | 128,10 | 128,85 | 127,06 | 127,15 | -0,81% | 1,40% | 11.246.100 |
| 28/02/2024 | 129,34 | 129,40 | 127,70 | 128,19 | -0,65% | 1,31% | 5.697.200 |
| 27/02/2024 | 128,26 | 129,16 | 127,80 | 129,03 | +0,15% | 1,06% | 4.780.200 |
| 26/02/2024 | 129,38 | 129,70 | 128,47 | 128,84 | -0,47% | 0,95% | 5.158.400 |
| 23/02/2024 | 129,79 | 130,24 | 128,86 | 129,45 | +0,15% | 1,06% | 5.177.400 |
| 22/02/2024 | 128,15 | 129,72 | 127,65 | 129,26 | +0,89% | 1,62% | 6.517.400 |
| 21/02/2024 | 127,44 | 128,16 | 126,80 | 128,12 | +0,59% | 1,07% | 4.849.200 |
| 20/02/2024 | 128,13 | 129,29 | 127,21 | 127,37 | -0,33% | 1,62% | 6.952.800 |
| 16/02/2024 | 126,50 | 128,09 | 126,17 | 127,79 | +0,99% | 1,52% | 6.266.800 |
| 15/02/2024 | 125,97 | 127,23 | 125,95 | 126,54 | +0,57% | 1,02% | 5.756.700 |
| 14/02/2024 | 125,61 | 126,03 | 124,82 | 125,82 | +0,31% | 0,96% | 6.622.400 |
| 13/02/2024 | 125,98 | 126,86 | 124,48 | 125,43 | +0,07% | 1,89% | 7.273.400 |
| 12/02/2024 | 125,00 | 125,48 | 124,40 | 125,34 | -0,09% | 0,86% | 5.257.400 |
| 09/02/2024 | 126,22 | 126,69 | 125,04 | 125,45 | -0,92% | 1,31% | 7.891.200 |
| 08/02/2024 | 127,32 | 127,48 | 125,95 | 126,61 | -0,67% | 1,20% | 6.308.300 |
| 07/02/2024 | 126,90 | 128,06 | 126,50 | 127,47 | +0,47% | 1,23% | 6.742.800 |
| 06/02/2024 | 126,61 | 127,52 | 126,07 | 126,88 | +0,55% | 1,15% | 6.153.000 |
| 05/02/2024 | 126,98 | 127,80 | 125,70 | 126,18 | -0,18% | 1,65% | 8.027.700 |
| 02/02/2024 | 126,71 | 127,56 | 126,11 | 126,41 | +0,02% | 1,14% | 10.175.600 |
| 01/02/2024 | 123,65 | 126,43 | 122,77 | 126,38 | +4,64% | 2,96% | 11.650.700 |
| 31/01/2024 | 122,53 | 122,85 | 120,50 | 120,78 | -0,72% | 1,92% | 10.779.000 |
| 30/01/2024 | 121,28 | 121,76 | 120,18 | 121,66 | +0,31% | 1,30% | 7.469.500 |
| 29/01/2024 | 121,35 | 121,46 | 120,49 | 121,28 | +0,38% | 0,80% | 9.138.200 |
| 26/01/2024 | 120,51 | 121,02 | 120,08 | 120,82 | +0,57% | 0,78% | 8.300.300 |
| 25/01/2024 | 118,66 | 120,18 | 118,66 | 120,13 | +1,05% | 1,28% | 6.689.800 |
| 24/01/2024 | 119,70 | 119,95 | 118,44 | 118,88 | -0,80% | 1,26% | 5.859.900 |
| 23/01/2024 | 118,14 | 119,99 | 117,27 | 119,84 | +0,34% | 2,30% | 6.501.400 |
| 22/01/2024 | 119,04 | 119,97 | 118,86 | 119,43 | +0,45% | 0,93% | 8.786.200 |
| 19/01/2024 | 118,21 | 119,02 | 117,72 | 118,89 | +0,30% | 1,10% | 7.605.600 |